Venture Planning Group (www.VPGMarketResearch.com), an international publishing and management consulting firm, is pleased to announce the completion of a new 174-page report, “The 2011 US Flow Cytometry Market” (http://www.vpgmarketresearch.com/Hematology-Flow-Cytometry). The report is designed to help current suppliers and potential market entrants identify and evaluate major opportunities emerging in the US flow cytometry market during this decade.
This report presents a comprehensive analysis of the US flow cytometry market, including:
•Major issues pertaining to the US flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
•Five-year volume and sales forecasts for major flow cytometry tests performed in US hospitals and commercial laboratories.
•Annual placements and installed base of major flow cytometers.
•Review of current instrumentation technologies and a feature comparison of leading systems.
•Five-year reagent and instrument sales forecasts.
•Sales and market shares of leading reagent and instrument suppliers.
•Review of current and emerging diagnostic technologies, and their potential market applications.
•Product development opportunities for new instruments, consumables, and auxiliary products.
•Profiles of current and emerging suppliers, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and corporate strategies.
•Business opportunities and strategic recommendations for suppliers.
Contains 174 pages and 17 tables
To review or order this report, visit http://www.vpgmarketresearch.com/us-flow-cytometry.html
Contact
Robert Fisher
Healthcare Research
[email protected]
+1 212 564 2838
http://www.VPGMarketResearch.com
